Calpain 2 (Capn2) Vesicle-associated membrane protein 7 (Vamp7) C-type natriuretic peptide (Cnp) PC12 cells Animal model of depression A B S T R A C T Corticosterone (CORT), the main HPA-axis glucocorticoid hormone in rodents, is involved in the regulation of animal stress responses. However, the neural mechanisms underlying the effects of corticosteroids on depression are yet to be elucidated. We found that fluoxetine reversed neurite growth inhibition induced by CORT in PC12 cells, a widely used model system for neurobiological and neurotoxicological studies. Transcriptome profiling showed that 1,609 genes were up-regulated, whereas 1,764 genes were down-regulated significantly in the CORT group in comparison with the Control group. Of them, the expression of 589 DEGs was reversed after fluoxetine treatment, and genes related to cell morphogenesis, neurite growth, and immune function were involved in the neuroprotective effect of fluoxetine against CORT. Furthermore, expression of neurite growth-related genes, such as such as Calpain 2 (Capn2), vesicle-associated membrane protein 7 (Vamp7) and C-type natriuretic peptide (Cnp), altered in a brain region-or treatment-specific manner in the animal models of depression. Therefore, the interaction between stress, glucocorticoids, and neurite growth inhibition may be a candidate pathophysiology underlying major depressive disorder (MDD), and the identification of Capn2, Vamp7 and Cnp might provide insight into treatment of MDD.
Introduction
Environmental stress is a risk factor for various mental disorders, especially for depression. Glucocorticoid hormones are pivotal neuroendocrine signals, and play essential roles in the regulation of physiological response to stress (Gourley et al., 2013) . Corticosterone, the main hypothalamic-pituitary-adrenal (HPA)-axis glucocorticoid hormone in rodents, was shown to be involved in the regulation of animal stress responses. Elevated basal corticosterone concentration, caused by hyperactivity of the HPA axis and glucocorticoid receptor (GR) dysfunction, was considered as one of the major features of depression in both experimental animals and patients (Blackburn-Munro and Blackburn-Munro, 2001; Gong et al., 2015) . However, serum corticosterone concentration showed different dynamics under different physiological or stressful conditions (Liu et al., 2013; Wu et al., 2012) .
Glucocorticoid hormones play an important role in neuronal system development, metabolic regulation, and stress response (Colich et al., 2015; Roszkowski et al., 2016; Wang et al. 2015; Zhao et al., 2015) . Additionally, they have extensive effects on neural activity through the genomic regulation of gene transcription and other non-genomic pathways, which are mediated by their mineralocorticoid (MR) and glucocorticoid (GR) receptors (Joels et al., 2012) . In contrast, previous studies reported that high corticosterone concentrations and longlasting corticosterone treatment could induce neuronal cell damage (Du et al., 2009; Marasco et al., 2016; Zou et al., 2016) . Additionally, it was reported that glucocorticoids could significantly increase the amount of mitochondrial DNA, and reduce the length of telomeres in response to stress in an experimental animal model (Tomiyama et al., 2012) . Furthermore, an increase in circulating corticosterone concentration may lead to changes in multi-gene expression levels, resulting in a decrease in the concentration of physiologically important neurotropic factors and causing multi-systemic disorders (Mpofana et al., 2016; Roszkowski et al., 2016; Wong et al., 2008) . However, the neural mechanisms underlying the effects of corticosteroids on depression are yet to be elucidated.
The PC12 cell line is widely used as a model system for both the glucocorticoid-induced impairment of neuronal cells and their underlying molecular mechanisms (Terada et al., 2014) due to the particularly abundant distribution of glucocorticoid receptors in the cells (Fujita et al., 1989) . Previous studies investigated the effects of glucocorticoids on neurite outgrowth in PC12 cells (Pollock et al., 1990; Terada et al., 2014) . Our previous research also confirmed that corticosterone significantly affected PC12 cell viability through the alternation of multi-gene expression levels in intracellular MAPK pathways (Li et al., 2016) . To further explore the neural mechanisms underlying the effects of corticosteroids on depression, we performed transcriptome profiling to test the effect of fluoxetine, a wildly used antidepressant, on neurite growth inhibition induced by CORT in PC12 cells. Additionally, we examined the expression changes of target genes (chosen by bioinformatics) in two animal depression models induced by either unpredicted chronic mild stress or chronic corticosterone treatment.
Materials and methods
total of 24 ten-week-old male Sprague Dawley (SD) rats (Beijing Vital River Laboratory Animal Technology Co., Ltd, Beijing, China) were used for all experiments, which were strictly performed in accordance with the Guideline for Care and Use of Laboratory Animals of the Chinese Academy of Sciences. All protocols were approved by the Review Board of the Institute of Psychology, Chinese Academy of Sciences.
Drugs and reagents
Fluoxetine (CAS 56296-78-7; Melonepharma, Dalian, China) was dissolved in dimethyl sulfoxide (DMSO) to create a stock solution, while corticosterone and Cell Counting Kit-8 (CCK-8) were purchased from SIGMA-ALDRICH (Cat No. C2505; Saint Louis, MO, USA) and Beyotime (Cat. No. C0038; Beyotime Institute of Biotechnology, Haimen, China), respectively.
Cell culture
PC12 cells were obtained from the Cell Bank of the Chinese Academy of Sciences (Beijing, China) and maintained in the Dulbecco's modified Eagle's medium (DMEM) (Life Technologies, Grand Island, NY, USA) supplemented with 5% of fetal bovine serum (FBS) (Life Technologies, Grand Island, NY, USA), 5% of horse serum (Life Technologies, Grand Island, NY, USA), 100 µg/ml of streptomycin, and 100 U/ml of penicillin in a water-saturated atmosphere of 5% CO 2 at 37°C .
Cell treatment
PC12 cells were seeded into either 96-well dish for cell viability examination or 60-mm dish for RNA extraction with 3 × 10 3 cells/ well and 1 × 10 6 cells/well, respectively, and were cultured in serum-free medium for 12 h prior to drug treatment. Additionally, cells were treated with 50 uM CORT and various concentrations of fluoxetine (0-100 ng/ml) for 24 h, while cell viability was measured by CCK-8 assay. The CORT concentration was chosen according to our previous study which could reduce both live cell numbers and cellular neurite outgrowth (Li et al., 2016) . PC12 cells were divided into Control, CORT, and CORT (50 uM) plus fluoxetine (5, 10, 100 ng/ ml) treatment groups. The cells in both of the control and treatment groups were harvested after 24 h following either CORT or fluoxetine treatment.
RNA sequencing (RNA-seq)
Total RNA of the control and drug-treated PC12 cells was extracted using Trizol (Life Technologies, Grand Island, NY, USA). Both, the quantity and the quality, of the extracted RNA were evaluated using the NanoDrop spectrophotometer (Thermo Scientific, Wilmington, DE, USA) and Agilent 2100 Bioanalyzer with calculation of RNA integrity number (RIN) (Agilent Technologies, Santa Clara CA, USA), respectively. All RNA samples were applied for the next generation RNA sequencing when the sample RIN > 7 and the total RNA quantity > 400 ng. Nine sequencing libraries (3 Control groups, 3 CORT and 3 CORT plus 100 ng/ml fluoxetine treatment groups) were constructed with the NEBNext Ultra RNA Library Prep Kit for Illumina with poly(A) messenger RNA selection (New England Biolabs, Ipswich, MA, USA), according to the manufacturer's instructions. Thereafter, the libraries were used to build clusters on the Illumina cell flow according to the manufacturer's protocol. Finally, sequencing was performed using the Illumina HiSeq 2500 System (Illumina, San Diego, CA, USA) with a 150-bp paired-end sequencing strategy.
Bioinformatic processing of the RNA-seq data
The quality of raw sequencing reads was evaluated by using the FastQC package, and then Cutadapt was used to remove adapters and low quality reads (Martin, 2011 ). The clean reads were then mapped into the rat reference genome and transcriptome downloaded from the UCSC Genome Browser (http://www.genome.ucsc.edu) (rn5 assembly) through the Tophat2 (Trapnell et al., 2009) . Only uniquely mapped reads were used in this analysis. Fragments Per Kilobase of sequence per Million mapped reads (FPKM) were used to normalize the number of aligned reads by the size of the gene and the total number of mapped reads. Additionally, the changes in gene expression between different groups were analyzed using the Cufflinks 2.0 package (Trapnell et al., 2012) . Genes with FDR (False Discovery Rate) value < 0.05 were referred to as differentially expressed genes (DEGs).
We further identified the statistically enriched functional terms from the public databases of the Gene Ontology (GO) (http:// geneontology.org/); functional terms with a FDR value < 0.05 represented a statistically significant enrichment.
Validation of differentially expressed genes
cDNA was synthesized from 1 µg of total RNA (template) using Superscript III (Invitrogen, CA, USA). The validation of differentially expressed genes (DEGs) was determined by real-time quantitative PCR using the SYBR Green Mix (CWBIO, Beijing, China) on Applied Biosystems ABI 7500 (Applied Biosystems, CA, USA). PCR conditions were: 95°C for 10 min, 40 cycles at 95°C for 10 s, 60°C for 60 s, and signal detection for 10 s. The dissociation curve analysis was performed at the end of each run, whereas the relative mRNA expression was determined by the standard ΔΔ Ct method using the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a normalization control. The primers for target genes design by software PerlPrimer (Marshall, 2004) were listed in Table 1 , and specificity of each primer was validated using gel electrophoresis.
Chronic unpredicted mild stress (CUMS)
The time schedule followed for the CUMS procedure was previously reported in different studies Pan et al., 2014) . All rats were isolated into a single cage and subject to a variety of mild stressors, including cage tilting for 24 h, swimming in cold water at 4°C for 5 min, swimming in hot water at 45°C for 5 min, fasting for 48 h, water deprivation for 24 h, shaking for 10 min, nip tail for 1 min, wet bedding for 24 h, and inversion of the light/dark cycle. Rats were exposed to one of such stressors each day. The stress procedure lasted for eight weeks prior to behavioral testing, with food deprivation for 20 h representing the final stressor.
Chronic corticosterone (CORT) treatment
CORT was emulsified in propylene glycol (Fisher Scientific, Pittsburgh, PA, USA). Subsequently, either CORT or the vehicle was administered subcutaneously (s.c.) once per day, at a dose of 20 mg/kg of rats' body weight. Injections were administered between 09:00 and 11:00 for 21 consecutive days. The dose was selected based on previous studies which reported similar doses to be effective in inducing depression-like behavior in rats (Rosa et al., 2014) .
Data analysis
All the statistical analyses were performed with the GraphPad Prism 6.0 software. Comparisons of means of multiple groups with each other or with the Control group were performed using one-way ANOVA followed by Tukey's post-hoc tests. The means of relative gene expression between the two groups were compared with a two-tailed Student's ttest. Statistical significance was set at P < 0.05.
Results

Fluoxetine reversed corticosterone-induced cytotoxicity and inhibition of neurite growth in PC12 cells
Following the 24-h treatment of PC12 cells with 50 μM of CORT and various concentrations of fluoxetine (0-100 ng/ml), cell viability was remarkably reduced, with a significant difference between the Control and the CORT treatment groups (P<0.01). In contrast, co-treatment with fluoxetine enhanced cell viability at the dose of 100 ng/ml (P<0.05) (Fig. 1) . Considering that the protective effect of fluoxetine was observed at 100 ng/ml, cells treated with such a concentration of fluoxetine were used for transcriptome sequencing. Additionally, the microscopic observation showed that the neurites of CORT-treated PC12 cells were significantly shorter or even disappeared when compared to that of control cell, which was alleviated by co-treatment with fluoxetine (Fig. 2) .
Quality assessment of the sequenced data
We obtained 46,306,299 to 50,181,829 short reads of 150 bp from each replicate from the CORT-treated, the CORT-plus fluoxetinetreated, and Control groups. Of these, 90.34% to 91.78% were successfully aligned to a reference gene database (UCSC, version rn5) by TopHat (Trapnell et al., 2009 ) (Supp. Table 1 ).
CORT-induced expression changes were specifically reversed by fluoxetine
The analysis showed that when compared to the Control group, 1609 genes were up-regulated, whereas 1764 genes were down-regulated significantly in the CORT group. Of them, the expression of 589 DEGs was reversed after fluoxetine treatment). Through functional enrichment analysis, 23 groups were enriched for CORT-induced-DEGs whose expression changes can be reversed by fluoxetine treatment (Tables 2 and 3 ). The most significantly enriched GO items were related to cell morphogenesis (GO:0001763∼ morphogenesis of a branching structure), neurite growth (GO:0031143∼pseudopodium), immune function (GO:0010934∼macrophage cytokine production, GO:0016236∼macroautophagy), and cell growth/apoptosis (GO:0016071∼mRNA metabolic process, GO:0006397∼mRNA processing, GO:0008380∼RNA splicing, GO:0006281∼DNA repair and so on). It suggests that genes related to cell morphogenesis, neurite growth, and immune function might be involved in the neuroprotective effect of fluoxetine against CORT.
Validation of the expression changes of pseudopod extensions-related genes by qRT-PCR
Consistent with the morphological changes in PC12 cells, we found that three differentially expressed genes (Capn2, Vamp7 and Cnp) were involved in pseudopod extensions (GO:0031143∼pseudopodium), which were essential for neurite outgrowth of PC12 cell (Dharmawardhane et al., 1999) . These genes were selected for validating the RNA-seq results by RT-qPCR. The RT-qPCR results showed that the significant alteration induced by CORT could be reversed by fluoxetine treatment, which coincided with the results obtained from RNA-sequencing except for Cnp (Supp. Fig. 1 ).
Chronic CORT treatments changed the expression of Capn2, Vamp and Cnp in various brain regions
Our unpublished data found that animals showed depressive like behavior after chronic CORT treatments. We further tested the effects of chronic CORT treatments on the expression of Capn2, Vamp and Cnp in various HPA axis function and stress-related brain regions. The results showed that Capn2 increased in the prefrontal cortex (PFC) (P<0.05), Fig. 1 . Fluoxetine alleviated corticosterone (CORT)-induced cytotoxicity. Cell viability in the Control, CORT (50 uM) and co-treatment of 50 uM CORT (C) with fluoxetine (F) groups. Data is expressed as the mean ± SEM (n = 12 for each group). **P < 0.01 compared with the Control group; # P < 0.05 compared with the CORT group.
M. Li, et al. Psychiatry Research 276 (2019) , and co-treatment of 50 uM CORT with 5 ng/ml (C), 10 ng/ml (D) and 100 ng/ml (E) fluoxetine, respectively. (F) Relative neurite growth is expressed as the mean ± SEM in the Control, CORT and co-treatment of CORT with fluoxetine groups (n = 4-8 for each group). ****P < 0.0001 compared with the Control group; #### P < 0.0001 compared with the CORT group; ## P < 0.01 compared with the CORT group. M. Li, et al. Psychiatry Research 276 (2019) 79-86 while it decreased in the hippocampus (Hip) (P<0.05). In contrast, Vamp increased in the raphe nuclei (RHN) (P<0.05), while it decreased in the Hip. Also, Cnp decreased in the Hip (P<0.05, n = 6) (Fig. 3) .
Chronic unpredicted mild stress (CUMS) changed the expression of Capn2, Vamp and Cnp in various brain regions
Our unpublished data also found that animals showed depressive like behavior after CUMS treatments. Here, we analyzed the effects of CUMS on expression of Capn2, Vamp and Cnp in the same brain regions as chronic corticosterone treatments. We found increased Capn2 expression in the PFC (P<0.01), RHN, and pituitary (Pit), while decreased expression was noted in both the thalamus (Tha) (P<0.001) and the Hip (P<0.05). In concordance, Vamp expression increased in both the RHN (P<0.01) and Pit (P = 0.05). Cnp expression increased in the RHN (P = 0.003), Pit, and PFC (P<0.01), while it decreased in the Hip (P<0.05, n = 6) and in the Tha (P<0.001) (Fig. 4) .
Discussion
The main findings of this paper include: 1) CORT-induced decrease of PC12 cell viability could be reversed by fluoxetine; 2) fluoxetine alleviated neurite growth inhibition induced by CORT in PC12 cells; 3) transcriptome profiling showed that the expression changes of 589 DEGs induced by CORT could be reversed by fluoxetine; 4) genes related to cell morphogenesis, neurite growth, and immune function were involved in the neuroprotective effect of fluoxetine against CORT; 5) expression of neurite growth-related genes, such as Capn2, Vamp7 and Cnp, altered in a brain region-or treatment-specific manner in two different animal models of depression.
Increasing evidence suggested that sustained stress or high level of glucocorticoids adversely affect neuroplasticity, a mechanism , and Pit (E), respectively. Data is expressed as the mean ± SEM (n = 6 for each group). *P ≤ 0.05; **P ≤ 0.01 ***P ≤ 0.001 compared with their corresponding Control group. Hip: hippocampus; PFC: prefrontal cortex; RHN: raphe nuclei; Tha: Thalamus; Pit: pituitary.
fundamental for neuronal adaptation of depression, which could be reversed by antidepressant treatment (Sapolsky, 2000) . Specifically, prolonged stress and excessive glucocorticoids have adverse effects at the cellular level, including dendrites processes retraction or neurite outgrowth inhibition (Li et al., 2003; Santarelli et al., 2003) . Our results showed that fluoxetine reversed neurite growth inhibition in PC12 cells induced by CORT, which were supported by several previous study. For example, it was reported that dexamethasone could bind to the GR and impair NGF-promoted neurite outgrowth by interfering with the activation/phosphorylation of Akt and ERK1/2 (Terada et al., 2014) . Additionally, repeated restraint stress in rats for 3 weeks caused dendrites atrophy of CA3 pyramidal neurons (McEwen et al., 1997) . These changes had been involved in a reduction in the amount of neuropil reported in post-mortem studies of the hippocampus of patients with major depression (Sapolsky, 2000) .
Furthermore, several signaling pathways were involved in both neuritogenesis and neurite outgrowth. To date, phospholipase C-g (PLCg), phosphatidylinositol-3 kinase (PI3K), the mammalian target of rapamycin (mTOR), p38 MAPK, c-Jun N-terminal kinase (JNK), Akt, heat shock protein Hsp90a, Wnt-3a, and the Ras/Raf/ERK/MAPK pathways have been identified to play a role in the NGF-induced neurite outgrowth in PC12 cells (Ishima et al., 2012; Selvaraj et al., 2015) . In the current study, we identified three new molecular factors, including Capn2, Vamp and Cnp, which may contribute to neurite outgrowth inhibition induced by CORT.
CALPAIN is an evolutionary conventional family of soluble, neutral, calcium-dependent cysteine proteases, which modify the activity/ function of their substrate proteins through protein cleavage (Baudry and Bi, 2016) . Calpain has a widespread role in synaptic plasticity via cytoskeletal regulation, AMPA receptor trafficking, actin polymerization and regulation of local protein synthesis (Baudry and Bi, 2016) . Recent studies demonstrated that calpain participated in the regulation of dendritic structure by RhoA and p70S6K (Baudry and Bi, 2016) . Capn2 (m-calpain catalytic subunit) belongs to the calpain family and has a well-established causal role in the survival of primary hippocampal neurons following NMDA excitotoxicity (Bevers et al., SYBL1/VAMP7, also referred to as tetanus toxin-insensitive vesicleassociated membrane protein or TI-VAMP, mediates the fusion of intracellular vesicles and the plasma membrane. VAMP7 has an extensive distribution in the adult brain and was implicated in actin remodeling during neurite outgrowth (Alberts et al., 2006; Coco et al., 1999) . Furthermore, VAMP7-mediated exocytosis was involved in neuritogenesis through the regulation of membrane delivery coordinated with the actin cytoskeleton (Baudry and Bi, 2016) . In addition, loss of VAMP7 reduced AMPA mEPSCs and led to subsequent resting NMDA receptor activation, causing inhibition of synaptic plasticity (Crawford et al., 2017) . Furthermore, in vivo evidence showed that VAMP7 contributed to myelin biogenesis by delivering the cargo to the myelin membrane (Feldmann et al., 2011) . Importantly, VAMP7 knocked-out male mice showed higher unconditioned basal anxiety level when compared to controls (Danglot et al., 2012) .
CNP is an abundant neuropeptide in both the human brain and the cerebrospinal fluid and plays diverse functions in central nervous system. For example, CNP was involved in anxiogenesis, representing a ligand that induces bifurcation of ingrowing sensory axons via its receptor Npr2 (Schmidt et al., 2009) . Additionally, CNP caused hyperpolarization of CA3 neurons which increases their input resistance and decreases their inhibitory conductance (Decker et al., 2009 ). Furthermore, CNP was shown to inhibit brain derived neurotrophic factor and nerve growth factor-induced proliferation of olfactory neuronal precursors and promote differentiation (Simpson et al., 2002) . CNP in the sensory nerve was necessary for development and function of dorsal root ganglion (DRG) neurons (Kishimoto et al., 2008) .
Together, Capn2, Vamp7 and Cnp participated in neuroplasticity at numerous levels, especially in anxiogenesis, neuritogenesis and neurite growth. Our results showed that both inhibition of neurite growth and changes in the expression of Capn2, Vamp7 and Cnp induced by CORT treatment could be reversed by fluoxetine. To further investigate the potential role of Capn2, Vamp7 and Cnp in depression, we tested the changes of their expression in stress related brain regions in two animal models of depression. Our results showed that all three genes are downregulated in the hippocampus after chronic CORT treatment, and in the thalamus after CUMS. They also showed some inconsistence between cell and animal model. Some reasons might be used to explain these differences. Firstly, although PC12 cell line was widely used to investigate the glucocorticoid-induced impairment of neuronal cells, as a cell line derived from a pheochromocytoma of the rat adrenal medulla, it couldn't act like normal physiological neuronal cells. So, it may display different physiological response to the tested challenges. Secondly, the absence of the in vivo biokinetics may lead to a misinterpretation of the in vitro data (Saeidnia et al., 2015) . The varying responses among the brain regions induced by CUMS and chronic CORT treatment implying brain-region-specific response in vivo after depression. Of note, Capn2 showed consistent increase in CORT treated cell line and in PFC of both depressive models, indicating the functional importance of Capn2 in etiology of depression. However, although PC12 cells and two animal models of depression were used to examine the expression alteration of target genes, functional neurons were also needed in the further study to elucidate the mechanism underlying depression.
Conclusions: Given the clear relationship among stress, excessive glucocorticoids and major depression, our results suggested that the interaction between stress, glucocorticoids and neurite growth inhibition may be a candidate for the underlying pathophysiology of major depressive disorder (MDD), and that Capn2, Vamp7 and Cnp may represent potential targets for the treatment of MDD.
